| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Center for Integrative Genomics, National Center of Competence in Research "Frontiers in Genetics" (L.M., J.N.F., L.G., H.K., B.D., W.W.), and Department of Medicine (T.P.), University of Lausanne, CH-1015 Lausanne, Switzerland
Address all correspondence and requests for reprints to: L. Michalik or W. Wahli, Centre Intégratif de Génomique, Université de Lausanne, Le Génopode, CH-1015 Lausanne, Switzerland. E-mail: liliane.michalik{at}unil.ch or walter.wahli{at}unil.ch.
Many nuclear hormone receptors are involved in the regulation of skin homeostasis. However, their role in the epithelial compartment of the skin in stress situations, such as skin healing, has not been addressed yet. The healing of a skin wound after an injury involves three major cell types: immune cells, which are recruited to the wound bed; dermal fibroblasts; and epidermal and hair follicle keratinocytes. Our previous studies have revealed important but nonredundant roles of PPAR
and ß/
in the reparation of the skin after a mechanical injury in the adult mouse. However, the mesenchymal or epithelial cellular compartment in which PPAR
and ß/
play a role could not be determined in the null mice used, which have a germ line PPAR gene invalidation. In the present work, the role of PPAR
was studied in keratinocytes, using transgenic mice that express a PPAR
mutant with dominant-negative (dn) activity specifically in keratinocytes. This dn PPAR
lacks the last 13 C terminus amino acids, binds to a PPAR
agonist, but is unable to release the nuclear receptor corepressor and to recruit the coactivator p300. When selectively expressed in keratinocytes of transgenic mice, dn PPAR
13 causes a delay in the healing of skin wounds, accompanied by an exacerbated inflammation. This phenotype, which is similar to that observed in PPAR
null mice, strongly suggests that during skin healing, PPAR
is required in keratinocytes rather than in other cell types.
NURSA Molecule Pages Link:
This article has been cited by other articles:
![]() |
M. H. Liu, J. Li, P. Shen, B. Husna, E. S. Tai, and E. L. Yong A Natural Polymorphism in Peroxisome Proliferator-Activated Receptor-{alpha} Hinge Region Attenuates Transcription due to Defective Release of Nuclear Receptor Corepressor from Chromatin Mol. Endocrinol., May 1, 2008; 22(5): 1078 - 1092. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Tudor, J. N. Feige, H. Pingali, V. B. Lohray, W. Wahli, B. Desvergne, Y. Engelborghs, and L. Gelman Association with Coregulators Is the Major Determinant Governing Peroxisome Proliferator-activated Receptor Mobility in Living Cells J. Biol. Chem., February 16, 2007; 282(7): 4417 - 4426. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Michalik, J. Auwerx, J. P. Berger, V. K. Chatterjee, C. K. Glass, F. J. Gonzalez, P. A. Grimaldi, T. Kadowaki, M. A. Lazar, S. O'Rahilly, et al. International Union of Pharmacology. LXI. Peroxisome Proliferator-Activated Receptors Pharmacol. Rev., December 1, 2006; 58(4): 726 - 741. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Peraza, A. D. Burdick, H. E. Marin, F. J. Gonzalez, and J. M. Peters The Toxicology of Ligands for Peroxisome Proliferator-Activated Receptors (PPAR) Toxicol. Sci., April 1, 2006; 90(2): 269 - 295. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |